BlackRock Advantage International Inv C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
BlackRock Advantage International Fund Investor C Shares BROCX
- NAV / 1-Day Return 24.30 / +0.08 %
- Total Assets 8.8B
-
Adj. Expense Ratio
1.500%
- Expense Ratio 1.500%
- Distribution Fee Level Low
- Share Class Type Level Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.75%
- Turnover 113%
USD | NAV as of Jun 16, 2026 | 1-Day Return as of Jun 16, 2026, 10:05 PM GMT+0
Morningstar’s Analysis BROCX
Will BROCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the BROCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of BROCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 16.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV | 3.55 | 296M | Technology |
BlackRock Liquidity T-Fund Instl | 1.78 | 148M | Cash and Equivalents |
ABB Ltd | 1.63 | 135M | Industrials |
Banco Santander SA | 1.55 | 129M | Financial Services |
Shell PLC | 1.51 | 126M | Energy |
HSBC Holdings PLC | 1.40 | 117M | Financial Services |
AXA SA | 1.40 | 117M | Financial Services |
Nestle SA | 1.33 | 110M | Consumer Defensive |
Sanofi SA | 1.30 | 108M | Healthcare |
Siemens AG | 1.30 | 108M | Industrials |
United States